AMPH - Amphastar P - Stock Price & Dividends

Amphastar Pharmaceuticals, Inc. is a bio-pharmaceutical company that specializes in developing, manufacturing, marketing, and selling a range of generic and proprietary products, primarily in the injectable, inhalation, and intranasal segments. With operations in the United States, China, and France, the company caters to a diverse customer base.

The company's product portfolio includes BAQSIMI, a nasal spray designed to treat severe hypoglycemia, and Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma. Additionally, Amphastar offers Enoxaparin, a medication used to prevent and treat deep vein thrombosis, as well as REXTOVY and Naloxone for opioid overdose.

In the emergency care segment, the company provides a range of products, including Glucagon for injection emergency kits, Cortrosyn for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency, and Amphadase, an injection to absorb and disperse other injected drugs. Furthermore, Amphastar offers Epinephrine injection for allergic reactions, Lidocaine jelly and topical solution for various procedures, and Phytonadione injection, a vitamin K1 injection for newborn babies.

The company's product lineup also includes emergency syringe products, morphine injection for use with patient-controlled analgesia pumps, and Lorazepam injection for surgery and medical procedures. Moreover, Amphastar offers Neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants, as well as Isoproterenol hydrochloride injection for mild or transient episodes of heart block.

In addition to its marketed products, Amphastar distributes recombinant human insulin APIs and porcine insulin API. The company is also actively developing generic product candidates, including injectable, inhalation, and analytical technologies, as well as biosimilar product candidates and intranasal epinephrine for the treatment of allergic reactions.

Founded in 1996, Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California, and has established itself as a significant player in the bio-pharmaceutical industry. For more information, please visit the company's website at https://www.amphastar.com.